| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1307231-10-2 | 4-溴-2-(((叔-丁基二甲基硅烷基)氧基)甲基)吡啶 | C12H20BrNOSi |
| 1307231-21-5 | N-[(1S)-4-溴-2,3-二氢-1H-茚-1-基]氨基甲酸叔丁酯 | C14H18BrNO2 |
| 1307233-93-7 | N-[(4-氨基苯基)亚氨基甲基]氨基甲酸己酯盐酸盐 | C14H21N3O2.HCl |
| 1307233-94-8 | N-[[2-(氯甲基)-1-甲基-1H-苯并咪唑-5-基]羰基]-N-2-吡啶基-beta-丙氨酸乙酯 | C20H21ClN4O3 |
| 1307296-03-2 | L-谷氨酰胺 乳清酸盐 | C5H10N2O3.C5H4N2O4 |
| 1307298-34-5 | 1,2:4,5-二-O-(1-甲基亚乙基)-D-myo-肌醇 3,6-二丁酸酯 | C20H32O8 |
| 1307803-44-6 | JWH-0186-羟基吲哚 | C24H23NO2 |
| 1307803-52-6 | JWH-073丁酸溴化物 | C23H19NO3 |
| 1307859-67-1 | B-[3-(4-二苯并噻吩基)苯基]硼酸 | C18H13BO2S |
| 1307873-37-5 | (1S)-4-溴-2,3-二氢-1H-茚-1-胺盐酸盐 | C9H10BrN.HCl |
| 1307899-44-0 | 4,8-二溴-6-(2-乙基己基)-[1,2,5]噻二唑并[3,4f]苯并三唑 | C14H17Br2N5S |
| 1308256-94-1 | (alphaS)-3'-氯-alpha-[[(1S)-2-乙氧基-1-甲基-2-氧代乙基]氨基][1,1'-联苯]-4-丙酸 | C20H22ClNO4 |
| 1308278-50-3 | 卡利拉嗪 D8 | C21H24D8Cl2N4O |
| 1308292-89-8 | 14-[(4-氯苯基)氨基]-3,12,14-三亚氨基-2,4,11,13-四氮杂十四烷酰胺 | C16H26ClN9O |
| 1308384-58-8 | 咪唑并[1,2-b]哒嗪-3-羧酸 | C7H5N3O2 |
| 1308631-40-4 | N-(4-氯-2-氟苯基)-2-羟基苯甲酰胺 | C13H9ClFNO2 |
| 1308652-64-3 | 9-[2-(二环己基膦基)苯基]-9H-咔唑 | C30H34NP |
| 1308671-90-0 | 3-(5-溴-2-噻吩基)-2,5-双(2-乙基己基)-2,5-二氢-6-(2-噻吩基)吡咯并[3,4-c]吡咯-1,4-二酮 | C30H39BrN2O2S2 |
| 1308672-74-3 | 索凡替尼 | C24H28N6O3S |
| 1308872-02-7 | N-[2-(乙酰氨基)-2-脱氧-6-O-(alpha-L-吡喃岩藻糖基)-beta-D-吡喃葡萄糖基]-N2-芴甲氧羰基-L-天冬氨酰胺 | C33H41N3O14 |
| 1309040-96-7 | 9a-羟基雷米普利二氧代哌嗪 | C23H30N2O5 |
| 1309048-48-3 | 甲基 7-氯-6,7,8-三脱氧-6-[[[(2S,4R)-1-甲基-4-丙基-2-吡咯烷基]羰基]氨基]-1-硫代-L-苏式-alpha-D-乳-吡喃辛糖苷 2,4-双(磷酸二氢酯) | C18H35ClN2O11P2S |
| 1309079-08-0 | (1S,4aR,6S,6aR,7S,10aR,11aS,11bS)-1,6-二(乙酰氧基)-1,2,3,4,4a,5,6,6a,7,9,10a,11,11a,11b-十四氢-4a,10a-二羟基-4,4,11b-三甲基-9-氧代菲并[3,2-b]呋喃-7-羧酸甲酯 | C25H34O10 |
| 1309112-13-7 | 瑞格列奈酰基-beta-D-葡糖苷酸 | C33H44N2O10 |
| 1309268-54-9 | 5-甲基-5-(4-哌啶基)-2,4-咪唑烷二酮 | C9H15N3O2 |
| 1309283-31-5 | 2-(1-哌嗪基)嘧啶 | C8H4D8N4 |
| 1309349-64-1 | 3'(6')-去氢克林霉素磷酸酯 | C18H32ClN2O8PS |
| 1309357-15-0 | CX-4945 sodium salt | C19H11ClN3NaO2 |
| 1309362-77-3 | Cerberic acid B | C10H10O5 |
| 1309371-03-6 | 2-三氟甲基-2'-甲氧基查耳酮 | C17H13F3O2 |
| 1309435-60-6 | GPR40 Activator 1 | C31H31NO3S |
| 1309443-98-8 | 2-甲氧基-6-甲基-4-吡啶基-硼酸 | C7H10BNO3 |
| 1309443-99-9 | 2,5-二甲基-4-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-吡啶 | C13H20BNO2 |
| 1309444-75-4 | K145 | C18H24N2O3S |
| 1309446-14-7 | (11bS)-4-羟基-2,6-二(2,4,6-三环己基苯基)-二萘并[2,1-d:1',2'-f][1,3,2]二氧杂磷杂卓 4-氧化物 | C68H81O4P |
| 1309463-38-4 | 4-脱氧-4-氟-1,2,3,6-四-O-苯甲酰基-alpha-D-甘露糖 | C34H27FO9 |
| 1309478-07-6 | Wittifuran X | C15H12O5 |
| 1309560-49-3 | (4S,12aR)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12a-六氢-7-羟基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-b][1,3]恶嗪-9-甲酰胺 | C20H19F2N3O5 |
| 1309560-63-1 | 卡博特韦钠异构体 | C19H18F2N3NaO5 |
| 1309573-60-1 | alpha-[4-[[3,4-二氢-2,5,7,8-四甲基-2-(4,8,12-三甲基十三烷基)-2H-1-苯并吡喃-6-基]氧基]-1,4-二氧代丁基]-omega-甲氧基-聚氧乙烯 | |
| 1309575-43-6 | (4S,12aR)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12a-六氢-7-羟基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-b][1,3]恶嗪-9-甲酰胺钠盐 | C20H18F2N3O5.Na |
| 1309589-47-6 | 4-(苄基(乙基)氨基)丁-2-炔-1-醇 | C13H17NO |
| 1309664-75-2 | L-天冬氨酰胺酰-L-亮氨酰-L-丝氨酰-L-丝氨酰-L-丙氨酰-L-alpha-谷氨酰-L-缬氨酰-L-缬氨酰-L-缬氨酸 | C39H68N10O15 |
| 1309682-18-5 | 4-(2-氨基[1,2,4]三唑并[1,5-a]吡啶-6-基)-2,6-二甲基苯酚 | C14H14N4O |
| 1309684-94-3 | RO 8994 | C31H31Cl2FN4O4 |
| 1309781-36-9 | S-[2-羟基-2-(4-羟基苯基)乙基]-L-谷胱甘肽 | C18H25N3O8S |
| 1309781-40-5 | S-[2-羟基-1-(4-羟基苯基)乙基]-L-谷胱甘肽 | C18H25N3O8S |
| 1309784-09-5 | ITK抑制剂2 | C25H33N5O2 |
| 1309788-49-5 | 6,6-二甲基-4,5,6,7-四氢-1H-吲唑 | C9H14N2 |
| 1309788-69-9 | 2-(6,6-二甲基-4,5,6,7-四氢-1H-吲唑-3-基)-N-甲基-1H-吲哚-6-胺 | C20H29N4 |